$AQST News is ...our petition to stop a competitor didn’t work. All is well with aqst though. In fact. FDA response raises the approval possibility, already high, with liberant. Consider that liberant isn’t even calculated into earnings anyway. Which... raises surprise earnings factor. All around a non news event. But I love that liberant is not included in earnings. I didn’t know that. A big positive !!!